摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4′-pyridyl)-5-(3′-methoxyphenyl)-1,2,4-oxadiazole | 331989-56-1

中文名称
——
中文别名
——
英文名称
3-(4′-pyridyl)-5-(3′-methoxyphenyl)-1,2,4-oxadiazole
英文别名
4-[5-(3-Methoxyphenyl)-1,2,4-oxadiazol-3-yl]pyridine;5-(3-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole
3-(4′-pyridyl)-5-(3′-methoxyphenyl)-1,2,4-oxadiazole化学式
CAS
331989-56-1
化学式
C14H11N3O2
mdl
——
分子量
253.26
InChiKey
GARQYXHURFLLAG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    455.0±55.0 °C(Predicted)
  • 密度:
    1.226±0.06 g/cm3(Predicted)
  • 溶解度:
    3.5 [ug/mL]

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    61
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    4-氰基吡啶吡啶盐酸羟胺 、 sodium hydroxide 作用下, 以 乙醇甲苯 为溶剂, 反应 8.0h, 生成 3-(4′-pyridyl)-5-(3′-methoxyphenyl)-1,2,4-oxadiazole
    参考文献:
    名称:
    Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screening
    摘要:
    Ataluren, also known as PTC124, is a 5-(fluorophenyI)-1,2,4-oxadiazolyl-benzoic acid suggested to suppress nonsense mutations by readthrough of premature stop codons in the mRNA. Potential interaction of PTC124 with mRNA has been recently studied by molecular dynamics simulations highlighting the importance of H-bonding and stacking pi-pi interactions. A series of non-acidic analogues of PTC124 were selected from a large database via a ligand-based virtual screening approach. Eight of them were synthesized and tested for their readthrough activity using the Fluc reporter harboring the UGA premature stop codon. The most active compound was further tested for suppression of the UGA nonsense mutation in the bronchial epithelial IB3.1 cell line carrying the W1282X mutation in the CFTR gene. (C) 2016 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2016.06.048
点击查看最新优质反应信息